Toll Free: 1-888-928-9744

Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016

Published: Mar 11, 2016 | Pages: 59 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. 

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Diabetic Gastroparesis Therapeutics Clinical Trials 25 Prominent Drugs 27 Latest Clinical Trials News on Diabetic Gastroparesis 28 Mar 01, 2016: Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility 28 Feb 17, 2016: Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 28 Clinical Trial Profile Snapshots 29 Appendix 56 Abbreviations 56 Definitions 56 Research Methodology 57 Secondary Research 57 About GlobalData 58 Contact Us 58 Disclaimer 58 Source 59
List of Tables
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2016* 5 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9 Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Diabetic Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13 Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27


List of Figures
Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9 Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13 Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Diabetic Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Diabetic Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Diabetic Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25 Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27 GlobalData Methodology 57

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify